Resources for Food and Drug Administration (FDA)

FDA approves revolutionary laser for wide-use pain relief

www.citizen-times.com

Dr. Dru’s Chiropractic, Dru Aguilar, 438 Montford Ave., announces the Food and Drug Administration’s (FDA) approval of the Erchonia3LT laser to use for pain relief in patients suffering from chronic and acute pain. The laser, created by Dallas-based Erchonia, has been proven through extensive testing to significantly reduce the level of pain symptomatic with a number of ailments.

The Erchonia3LT is the first and only low-level laser approved for use in reducing pain. By contrast to the high-power, high-heat lasers that are used in various surgical procedures, Erchonia lasers produce a low-level, or cold, output that has no thermal effect on the body’s tissue. Instead, the laser serves to stimulate biological function positively. Low-level laser therapy is commonly used to treat conditions such as acute and chronic pain in a number of medical areas without negative side effects.

View the Resource

Share or bookmarklet this web page at: